Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
GC Biopharma Receives a Business License for the Construction of a Plasma Fractionation Plant and Technology Transfer in Indonesia
GC Biopharma, a South Korean biopharmaceutical company, has announced that it has successfully obtained final […]
Acurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its Board of Directors
Acurex Biosciences, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces […]
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, today […]
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]
Malaysian Genomics Inks Expansion Agreement in Bangladesh
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced a strategic […]
Asahi Kasei Bioprocess America and GeminiBio Enter Strategic Partnership
Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio […]
TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics
TORL BioTherapeutics, a biopharmaceutical company focused on developing new biologics for cancer treatment, has announced […]
Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has […]
Sage Therapeutics Appoints Jessica Federer to Board of Directors
Sage Therapeutics, a biopharmaceutical company leading the way to create a world with better brain […]
Personalis Selected for Clinical Research by AstraZeneca After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
Personalis, a leader in advanced genomics for precision oncology, today announced it will continue its […]
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
- Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
- Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
- Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
- Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more